Anti-diabetic Biguanides Inhibit Hormone-induced Intracellular Ca2+ Concentration Oscillations in Rat Hepatocytes
Overview
Authors
Affiliations
Rat hepatocytes respond to glycogenolytic stimuli acting via phosphoinositide breakdown (e.g. alpha 1-adrenergic agonists, vasopressin) by oscillations of the free intracellular Ca2+ concentration ([Ca2+]i). We have investigated the action of metformin and phenformin, two anti-diabetic drugs of the biguanide type, on phenylephrine-induced [Ca2+]i oscillations. Metformin and phenformin lowered the frequency of the [Ca2+]i oscillations in a concentration-dependent manner with an IC50 of 0.1 mM and 1 microM, respectively. Simultaneous addition of the biguanides and insulin resulted in a further reduction of the frequency. By contrast, agents which increase the cellular cyclic AMP (cAMP) concentration (glucagon, forskolin, N,2'-O-dibutyryl-cAMP) reversed this inhibition. Furthermore, we investigated whether biguanides influenced the agonist-induced Ca2+ influx across the plasma membrane. When hepatocytes were loaded with the acetoxymethyl ester of fura-2 (fura-2/AM), addition of Mn2+ led to a quench of cellular fura-2, measured at the isosbestic excitation wavelength of 360 nm, until a new steady state was reached. Surprisingly, however, this addition of Mn2+ caused a marked increase of the fluorescence ratio simultaneously measured at 340 and 380 nm during the approach of the 360 nm signal to a new steady state. This observation can be understood on the basis of a compartmentalization of fura-2/AM into intracellular stores sensing the [Ca2+] therein. Subsequent application of phenylephrine resulted in a further decline of the fura-2 signal at 360 nm and a concomitant decrease of the fluorescence ratio. This second phase of the Mn2+ quench and the decrease of the fluorescence ratio could be diminished by addition of either 3 mM metformin or 30 microM phenformin. By contrast, when hepatocytes were loaded with fura-2/pentapotassium salt via a patch pipette, only the initial Mn(2+)-induced quench, measured at 360 nm, but no change of the fluorescence ratio, could be observed. The subsequent addition of phenylephrine and biguanides during the on-going quench caused no further changes, except for a fading oscillatory response. After loading hepatocytes with fluo-3 acetoxymethyl ester, the cells were permeabilized with 5 microM digitonin. Addition of inositol-1,4,5-trisphosphate (IP3) caused a rapid decrease of the remaining cellular fluorescence which could be effectively inhibited by 20 micrograms/ml heparin, indicating a release of Ca2+ from intracellular compartments mediated by IP3. This IP3-induced release of Ca2+ from intracellular stores could be diminished by prior addition of metformin and phenformin.(ABSTRACT TRUNCATED AT 400 WORDS)
Glucagon, cyclic AMP, and hepatic glucose mobilization: A half-century of uncertainty.
Rodgers R Physiol Rep. 2022; 10(9):e15263.
PMID: 35569125 PMC: 9107925. DOI: 10.14814/phy2.15263.
The Metformin Mechanism on Gluconeogenesis and AMPK Activation: The Metabolite Perspective.
Agius L, Ford B, Chachra S Int J Mol Sci. 2020; 21(9).
PMID: 32375255 PMC: 7247334. DOI: 10.3390/ijms21093240.
Fey S, Wrzesinski K Toxicol Sci. 2012; 127(2):403-11.
PMID: 22454432 PMC: 3355318. DOI: 10.1093/toxsci/kfs122.
Perturbation of myo-inositol-1,4,5-trisphosphate levels during agonist-induced Ca2+ oscillations.
Chatton J, Cao Y, Stucki J Biophys J. 1998; 74(1):523-31.
PMID: 9449352 PMC: 1299404. DOI: 10.1016/S0006-3495(98)77809-9.
Agonist-specific behaviour of the intracellular Ca2+ response in rat hepatocytes.
Chatton J, Cao Y, Stucki J Biochem J. 1998; 328 ( Pt 2):573-9.
PMID: 9371717 PMC: 1218957. DOI: 10.1042/bj3280573.